Carregant...
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas
A subset of diffuse large B-cell lymphomas (DLBCL) harbors concomitant rearrangements of MYC, BCL2 and BCL6 and is characterized by clinical aggressiveness and intrinsic refractoriness to standard chemo-immunotherapy. Commonly identified as “double or triple hit” lymphomas, these diseases represent...
Guardat en:
| Publicat a: | Cell Cycle |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004704/ https://ncbi.nlm.nih.gov/pubmed/27419806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1207839 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|